| 1888 Press Release | Technology News | Biotechnology News | Biotechnology RSS |  |
Latest Biotechnology News & Press Releases |
||
|
AnaSpec Introduces SensoLyteo 520 Calpain Kit
AnaSpec has announced the release of the SensoLyteÒ 520 Calpain Activity Assay Kit, the industry’s first longest wavelength FRET based calpain assay. By Anaspec Inc - November 19, 2009 |
|
AnaSpec Introduces Agr D1 & D2 Thiolactone GO™ Peptides
AnaSpec has announced the release of two structurally complex peptides, Agr D1 Thiolactone and Agr D2 Thiolactone, as part of its GO™ (catalog) peptides offering. By Anaspec Inc - November 13, 2009 |
|
AnaSpec Improves Sensitivity of SensoLyte® pNPP Alkaline Phosphatase Assays
AnaSpec’s SensoLyte® pNPP Alkaline Phosphatase Assay kits now contain a specially formulated pNPP substrate. By Anaspec Inc - November 10, 2009 |
|
Joost Oppenheim MD, Lab Chief - NCI, to give Keynote at the 8th Cytokines & Inflammation Conference
Joost Oppenheim, Laboratory Chief at the Laboratory of Molecular Immunoregulation - NCI Frederick, is to give a keynote presentation on a group of structurally diverse multifunctional host proteins called "alarmins", at GTCbio's 8th Cytokines & inflammation Conference on January 28-29, 2010 in San Diego, CA. By Gtcbio - October 28, 2009 |
|
Eurogentec Announces Agreement to Acquire AnaSpec, Inc
Eurogentec S.A. announces today a final agreement for the acquisition of AnaSpec Inc, a privately held proteomics company based in Fremont, California. By Anaspec Inc - October 24, 2009 |
|
GenScript Launches Guaranteed Gene-To-Protein Service Package Following The Technology Breakthrough From OptimumGene™ Gene Optimization
Benefiting from its patent-pending OptimumGene™ gene optimization technology breakthrough which can achieve a 10-fold or greater increase in protein expression, GenScript now offers a first-to-market guaranteed Gene-to-Protein custom service package. By Genscript - October 21, 2009 |
|
Physik Instrumente Adds Design And Manufacturing In The USA
PI -- a leading manufacturer of piezo systems, piezo stages, linear motors and precision motion-control equipment for photonics, bio-nanotechnology & semiconductor applications -- has added design and manufacturing in the US, specifically suited for the needs of the North American market, by working more closely with the customer’s engineering teams and budgets. By Pi Physik Instrumente L.p. -- Piezo Nano Positioning Motion Control - October 20, 2009 |
|
AnaSpec Introduces New Cys-Containing b-Amyloid Peptides
AnaSpec has added the following amyloid peptides to its selection: b-amyloid (1-40) S26C; b-amyloid (1-42) S26C dimer; b-amyloid (1-42) S26C and other Cys-containing b-amyloid peptides. By Anaspec Inc - October 20, 2009 |
|
Neumedicines Obtains $4.9M to Support Development of Preclinical Radiomitigator
Biomedical Advanced Research and Development Authority (BARDA) exercises milestone-based options for the development of HemaMax. By Neumedicines Inc. - October 19, 2009 |
|
AnaSpec Introduces Beta- Secretase Enzyme & Assay
As one of the world’s largest providers of beta-amyloid peptides and Alzheimer’s related research products, AnaSpec has announced its latest offering – the human recombinant beta-secretase enzyme. By Anaspec Inc - October 17, 2009 |
|
Chinese Chemical Plant Optimizes Water Treatment Using a Liqui-Cel Membrane Contactor System
A chemical plant in China is using a Liqui-Cel Membrane Contactor system to remove CO2 downstream of a single pass RO system. This design was selected over conventional two pass RO with a caustic injection system due to savings in capital and operating costs. By Membrana - October 16, 2009 |
|
AnaSpec Introduces Expanded Selection of Anti-Tau Antibodies
AnaSpec has announced the release of 4 additional new phosphospecific anti-Tau antibodies. By Anaspec Inc - October 14, 2009 |
|
Vaccines: All Things Considered Conference to be held by GTCbio on November 9-10, 2009 in Washington, DC
The 7th Annual Vaccines: “All Things Considered” conference is to be held this year in Washington, D.C. on Nov 9-10, 2009 by GTCbio. This conference promises to be the one-stop destination to gain updates and exposure on all aspects of vaccine research, development, regulations, and policy. By Gtcbio - October 07, 2009 |
|
AnaSpec Introduces Rat-Specific SensoLyte® 520 Renin Assay Kit
AnaSpec is pleased to announce the release of a rat renin specific assay – the SensoLyte® 520 Rat Renin Assay Kit. By Anaspec Inc - October 06, 2009 |
|
The Health Assessment of Biocom Technologies
Health assessment - Various kinds of professionals could benefit from using Biocom products. By Biocomtech - October 04, 2009 |
|
AnaSpec Introduces Z-Fish™ Anti-p53 Antibodies
AnaSpec has announced the release of a zebrafish specific p53 antibody, the Z-Fish™ Anti-p53. By Anaspec Inc - October 03, 2009 |
Quick-Med Technologies Shows FDA-cleared Nimbus Technology At Prestigious Skin And Wound Care Symposium
By Quick-med Technologies, Inc. - October 02, 2009 160 |
|
Biosearch Technologies Takes License To The Roche 5' Nuclease Patents
Biosearch Technologies, Inc. today announced that on September 16th, 2009 the company licensed from Roche Molecular Systems (Roche) a family of patents covering practice of the 5’ Nuclease process. By Biosearch Technologies, Inc - October 02, 2009 |
|
BioInquire,LLC Awarded Phase II STTR from NIH for Clinical Proteomics Software Development
BioInquire, LLC recieves an award of a Phase II Small Business Technology Transfer (STTR) grant totaling $747,000. The grant, entitled Development of Software for Comparative and Quantitative Clinical Proteomics, was awarded by the National Institute of Health. By Bioinquire / Ron Orlando - September 30, 2009 |
|
AnaSpec Introduces New HiLyte Fluor™ 405 Fluorescent Probe
AnaSpec has introduced the newest member of the HiLyte FluorTM family - HiLyte Fluor™ 405 (Ex/Em=404/428 nm), a bright blue fluorescent probe. By Anaspec Inc - September 30, 2009 |
|
AnaSpec Introduces Custom Services & Reagents for Hydrocarbon-Stapled Peptides
AnaSpec now offers custom synthesis of hydrocarbon-stapled peptides. By Anaspec Inc - September 19, 2009 |
|
Technological Developments Driving Global Biometrics Market
New technological developments and soaring demand will drive the growth of global biometrics market at a CAGR of around 18% (2010-2012), says RNCOS in its new report. By Rncos - September 12, 2009 |
Newtechbio Offers Bed Bug Mace(TM) Control Treatment for residential, hospitality and commercial application
By Newtechbio, Inc. - September 11, 2009 153 |
|
GenScript Established Biology Research Collaboration with Roche
GenScript expands its drug discovery services to assay development. By Genscript - September 11, 2009 |
|
GenScript Launches Antibody Sequencing Service Geared Toward Innovation
GenScript’s antibody sequencing service aims to accelerate antibody drug discovery and patent applications. By Sally Wang - September 04, 2009 |
|
Allen Roses, Director Deane Drug Discovery Institute, Keynote At Drug Discovery & Development Summit
Allen Rose, Director of The Deane Drug Discovery Institute – Duke University, is to give a keynote presentation at GTCbio’s 5th Modern Drug Discovery & Development Summit, on October 14th-16th, 2009, in San Diego, CA. By Gtcbio - August 27, 2009 |
Innovatrics releases major upgrade to ExpressID AFIS product
By Innovatrics - August 26, 2009 19 |
|
AnaSpec Introduces Calcein AM for Live Cell Staining
Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells. By Anaspec Inc - August 26, 2009 |
|
Perrigo acquires 85% in Vedants Drugs
The US-based Perrigo Company, one of the largest over-the-counter (OTC) pharmaceutical producers in the world, has acquired an 85 per cent stake in Mumbai-based Vedants Drugs and Fine Chemicals, with plans to make India a major global production base for the company. By Economic News - August 24, 2009 |
|
GenScript Launches 20% OFF Campaign Celebrating the 5th Anniversary of Peptide Service
GenScript celebrates its 5th anniversary for its peptide services by giving customers 20% off for standard peptide synthesis and modifications. By Genscript - August 22, 2009 |
| 1 2 3 4 5 6 7 8 Next Last Page |
| Search |
| Search Press Release: |
| Bookmark Biotechnology RSS |
|
|
